1-20 of 71
Editor's choice
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A

Free
Subject Area:
Hematology , Oncology
Yingjia Lu, Lina Zhang, Weiying Qu, Zhou Feng, Yuan Deng, Lin Zhao
Journal: Acta Haematologica
Acta Haematol (2024) 147 (6): 716–728.
https://doi.org/10.1159/000537773
Published Online: 17 February 2024
View articletitled, Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A
Open the PDF for Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A in another window
Journal Articles

Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide

Free
Subject Area:
Hematology , Oncology
Ram Vasudevan Nampoothiri, Lisa Avery, Ivan Pasic, Ioannis Prassas, Eleftherios Diamandis, Fotios V. Michelis
Journal: Acta Haematologica
Acta Haematol (2024) 147 (5): 511–524.
https://doi.org/10.1159/000535706
Published Online: 08 February 2024
View articletitled, Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide
Open the PDF for Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide in another window
Journal Articles

Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience

Free
Subject Area:
Karger e-Journal Backfile Collection 2023 , Hematology , Oncology
Jose Tinajero, Dat Ngo, Alfredo Puing, Paul Koller
Journal: Acta Haematologica
Acta Haematol (2023) 146 (6): 491–496.
https://doi.org/10.1159/000533346
Published Online: 09 August 2023
View articletitled, Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience
Open the PDF for Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience in another window
Journal Articles

Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia

Free
Subject Area:
Karger e-Journal Backfile Collection 2023 , Hematology , Oncology
Samantha A. Hershenfeld, Eshetu G. Atenafu, Steven Chan, Vikas Gupta, Dawn Maze, Andre Schuh, Hassan Sibai, Karen Yee, Arron D. Schimmer
Journal: Acta Haematologica
Acta Haematol (2023) 146 (5): 366–372.
https://doi.org/10.1159/000531484
Published Online: 14 June 2023
View articletitled, Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia
Open the PDF for Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia in another window
Journal Articles

Make Family Caregivers Visible, Valued, and Supported: An Interview with Patients’ Caregivers’ Advocate

Free
Subject Area:
Karger e-Journal Backfile Collection 2023 , Hematology , Oncology
Pia Raanani, Rachel Ledany
Journal: Acta Haematologica
Acta Haematol (2023) 146 (1): 49–53.
https://doi.org/10.1159/000527734
Published Online: 14 March 2023
View articletitled, Make Family Caregivers Visible, Valued, and Supported: An Interview with Patients’ Caregivers’ Advocate
Open the PDF for Make Family Caregivers Visible, Valued, and Supported: An Interview with Patients’ Caregivers’ Advocate in another window
Journal Articles

A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations

Free
Subject Area:
Hematology , Oncology
Sai Prasad Desikan, Farhad Ravandi, Naveen Pemmaraju, Marina Konopleva, Sanam Loghavi, Elias J. Jabbour, Naval Daver, Nitin Jain, Kelly S. Chien, Abhishek Maiti, Guillermo Montalban-Bravo, Tapan M. Kadia, Walid Macaron, Ricardo DeLumpa, Monica Kwari, Gautam Borthakur, Nicholas J. Short
Journal: Acta Haematologica
Acta Haematol (2022) 145 (5): 529–536.
https://doi.org/10.1159/000525566
Published Online: 17 June 2022
View articletitled, A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations
Open the PDF for A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations in another window
Journal Articles

Cross-Sectional and Longitudinal Construct Validity of the Generic KINDL-A(dult)B(rief) Questionnaire in Adults with Thrombophilia or with Hereditary and Acquired Bleeding Disorders

Available to Purchase
Subject Area:
Hematology , Oncology
Bruno Neuner, Sylvia von Mackensen, Bettina Kiesau, Henning Krampe, William J. McCarthy, Sarah Reinke, Dorothee Kowalski, Maria Shneyder, Hartmut Clausnizer, Angela Rocke, Ralf Junker, Ulrike Nowak-Göttl
Journal: Acta Haematologica
Acta Haematol (2021) 144 (2): 166–175.
https://doi.org/10.1159/000507602
Published Online: 30 March 2021
View articletitled, Cross-Sectional and Longitudinal Construct Validity of the Generic KINDL-A(dult)B(rief) Questionnaire in Adults with Thrombophilia or with Hereditary and Acquired Bleeding Disorders
Open the PDF for Cross-Sectional and Longitudinal Construct Validity of the Generic KINDL-A(dult)B(rief) Questionnaire in Adults with Thrombophilia or with Hereditary and Acquired Bleeding Disorders in another window
Journal Articles

Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias

Available to Purchase
Subject Area:
Hematology , Oncology
Abhishek Maiti, Miguel J. Franquiz, Farhad Ravandi, Jorge E. Cortes, Elias J. Jabbour, Koji Sasaki, Kayleigh Marx, Naval G. Daver, Tapan M. Kadia, Marina Y. Konopleva, Lucia Masarova, Gautam Borthakur, Courtney D. DiNardo, Kiran Naqvi, Sherry Pierce, Hagop M. Kantarjian, Nicholas J. Short
Journal: Acta Haematologica
Acta Haematol (2020) 143 (6): 567–573.
https://doi.org/10.1159/000506346
Published Online: 09 February 2021
View articletitled, Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias
Open the PDF for Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias in another window
Journal Articles

Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Available to Purchase
Subject Area:
Hematology , Oncology
Wael Alanazi, Shiyi Chen, Jeffrey H. Lipton, Dennis D. Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun D. Law, Zeyad Al-Shaibani, Jonas Mattsson, Fotios V. Michelis
Journal: Acta Haematologica
Acta Haematol (2021) 144 (1): 66–73.
https://doi.org/10.1159/000507536
Published Online: 09 February 2021
View articletitled, Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Open the PDF for Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome in another window
Journal Articles

Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia

Free
Subject Area:
Hematology , Oncology
Jonas Westhus, Richard Noppeney, Christine Schmitz, Michael Flasshove, Ulrich Dührsen, Maher Hanoun
Journal: Acta Haematologica
Acta Haematol (2020) 143 (5): 438–445.
https://doi.org/10.1159/000503056
Published Online: 13 October 2020
View articletitled, Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia
Open the PDF for Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia in another window
Journal Articles

The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors

Available to Purchase
Subject Area:
Hematology , Oncology
Omar Alkharabsheh, M. Hasib Sidiqi, Mohammed A. Aljama, Morie A. Gertz, Arthur E. Frankel
Journal: Acta Haematologica
Acta Haematol (2020) 143 (2): 118–123.
https://doi.org/10.1159/000500976
Published Online: 31 March 2020
View articletitled, The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors
Open the PDF for The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors in another window
Journal Articles

Interview with a Patients’ Advocate

Free
Subject Area:
Hematology , Oncology
Pia Raanani, Giora Sharf
Journal: Acta Haematologica
Acta Haematol (2020) 143 (1): 1–4.
https://doi.org/10.1159/000502731
Published Online: 28 January 2020
View articletitled, Interview with a Patients’ Advocate
Open the PDF for Interview with a Patients’ Advocate in another window
Journal Articles

Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry

Available to Purchase
Subject Area:
Hematology , Oncology
Frederick Lansigan, Steven M. Horwitz, Lauren C. Pinter-Brown, Steven T. Rosen, Barbara Pro, Eric D. Hsi, Massimo Federico, Christian Gisselbrecht, Marc Schwartz, Lisa A. Bellm, Mark Acosta, Andrei R. Shustov, Ranjana H. Advani, Tatyana Feldman, Mary Jo Lechowicz, Sonali M. Smith, Anil Tulpule, Michael D. Craig, John P. Greer, Brad S. Kahl, Joseph W. Leach, Neil Morganstein, Carla Casulo, Steven I. Park, Francine M. Foss
Journal: Acta Haematologica
Acta Haematol (2020) 143 (1): 40–50.
https://doi.org/10.1159/000500666
Published Online: 28 January 2020
View articletitled, Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
Open the PDF for Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry in another window
Journal Articles

Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)

Available to Purchase
Subject Area:
Hematology , Oncology
Sanford Kempin, Zhuoxin Sun, Neil E. Kay, Elisabeth M. Paietta, Joseph J. Mazza, Rhett P. Ketterling, Olga Frankfurt, David F. Claxton, Joel N. Saltzman, Gordan Srkalovic, Natalie S. Callander, Gerald Gross, Martin S. Tallman
Journal: Acta Haematologica
Acta Haematol (2019) 142 (4): 224–232.
https://doi.org/10.1159/000500164
Published Online: 12 November 2019
View articletitled, Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)
Open the PDF for Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903) in another window
Journal Articles

A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature

Available to Purchase
Subject Area:
Hematology , Oncology
Hannah Levavi, Joseph Tripodi, Bridget Marcellino, John Mascarenhas, Amy V. Jones, Nicholas C.P. Cross, Diana Gruenstein, Vesna Najfeld
Journal: Acta Haematologica
Acta Haematol (2019) 142 (2): 105–112.
https://doi.org/10.1159/000498945
Published Online: 08 August 2019
View articletitled, A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature
Open the PDF for A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature in another window
Journal Articles

Top 100 Most Influential Articles in the Field of Myeloid Neoplasms: A Bibliometric Study

Available to Purchase
Subject Area:
Hematology , Oncology
Unzela Iqbal, Aiman Rehan, Manahil Akmal, Momal Jamali, Abiha Iqbal, Bilal Ahmed Khan, Khawaja Uzair Wasif, Erika Rivera, Maliha Khan
Journal: Acta Haematologica
Acta Haematol (2019) 141 (2): 68–78.
https://doi.org/10.1159/000493251
Published Online: 01 February 2019
View articletitled, Top 100 Most Influential Articles in the Field of Myeloid Neoplasms: A Bibliometric Study
Open the PDF for Top 100 Most Influential Articles in the Field of Myeloid Neoplasms: A Bibliometric Study in another window
Journal Articles

Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Available to Purchase
Subject Area:
Hematology , Oncology
Fabián Tarín, Francisco López-Castaño, Carmen García-Hernández, Paola Beneit, Héctor Sarmiento, Pablo Manresa, Olga Alda, Blanca Villarrubia, Margarita Blanes, Javier Bernabéu, Carmen Amorós, Sara Sánchez-Sánchez, Carmen Fernández-Miñano, Francisco De Paz, José Verdú-Belmar, Pascual Marco, Estella Matutes
Journal: Acta Haematologica
Acta Haematol (2019) 141 (1): 1–6.
https://doi.org/10.1159/000493568
Published Online: 15 January 2019
View articletitled, Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
Open the PDF for Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in another window
Journal Articles

Unmet Needs and Therapeutic Strategies in Cardio-Hemato-Oncology

Available to Purchase
Subject Area:
Hematology , Oncology
Nili Ronit Schamroth Pravda, Ran Kornowski
Journal: Acta Haematologica
Acta Haematol (2018) 140 (4): 226–230.
https://doi.org/10.1159/000493636
Published Online: 13 December 2018
View articletitled, Unmet Needs and Therapeutic Strategies in Cardio-Hemato-Oncology
Open the PDF for Unmet Needs and Therapeutic Strategies in Cardio-Hemato-Oncology in another window
Journal Articles

Bone Involvement in Hodgkin’s Lymphoma: Clinical Features and Outcome

Available to Purchase
Subject Area:
Hematology , Oncology
Francesco Gaudio, Pasquale Pedote, Artor Niccoli Asabella, Giuseppe Ingravallo, Paola Sindaco, Vito Alberotanza, Tommasina Perrone, Fiomena Emanuela Laddaga, Giuseppe Rubini, Amato Antonio Stabile Ianora, Giorgina Specchia
Journal: Acta Haematologica
Acta Haematol (2018) 140 (3): 178–182.
https://doi.org/10.1159/000490489
Published Online: 06 November 2018
View articletitled, Bone Involvement in Hodgkin’s Lymphoma: Clinical Features and Outcome
Open the PDF for Bone Involvement in Hodgkin’s Lymphoma: Clinical Features and Outcome in another window
Journal Articles

A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia

Available to Purchase
Subject Area:
Hematology , Oncology
Iman Abou Dalle, Jorge E. Cortes, Pramod Pinnamaneni, Betty Lamothe, Adolfo Diaz Duque, Jasleen Randhawa, Naveen Pemmaraju, Elias Jabbour, Alessandra Ferrajoli, William G. Wierda, Zeev Estrov, Marina Konopleva, Farhad Ravandi, Yesid Alvarado, Gautam Borthakur, Varsha Gandhi, Hagop M. Kantarjian
Journal: Acta Haematologica
Acta Haematol (2018) 140 (1): 30–39.
https://doi.org/10.1159/000490092
Published Online: 20 September 2018
View articletitled, A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Open the PDF for A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia in another window